Causes and associated factors with hospitalization in patients with systemic lupus erythematosus: Data from lupus multi-center registry in Argentina

被引:0
|
作者
Garcia, Lucila [1 ]
Gobbi, Carla Andrea [1 ]
Quintana, Rosana [1 ]
Virasoro, Belen [1 ]
Duran, Sandy Sapag [1 ]
Spindler, Alberto [1 ]
Alvarez, Analia Patricia [1 ]
Pisoni, Cecilia [1 ]
Gomez, Catalina [1 ]
Paniego, Raul Hector [1 ]
Cruz, Maria Julia Santa [1 ]
Lucero, Luciana Gonzalez [1 ]
Maldonado, Rodrigo aguila [1 ]
Gordon, Sergio [1 ]
Romero, Julia [1 ]
Rausch, Gretel [1 ]
Allievi, Alberto [1 ]
Orden, Alberto Omar [1 ]
Hereter, Johana Belen Zacariaz [1 ]
Baez, Roberto [1 ]
Gonzalez, Andrea Vanesa [1 ]
Vandale, Juan Manuel [1 ]
Goni, Mario Alberto [1 ]
Caputo, Victor Daniel [1 ]
Larroude, Maria Silvia [1 ]
Gomez, Graciela [1 ]
Marin, Josefina [1 ]
Collado, Victoria [1 ]
Martire, Maria Victoria [1 ]
Zelaya, Marcos David [1 ]
Sacnun, Monica [1 ]
Tessel, Romina Rojas [1 ]
Escobar, Maximiliano Machado [1 ]
Astesana, Pablo [1 ]
Paris, ursula Vanesa [1 ]
Garcia, Mercedes Argentina [1 ]
机构
[1] Argentinian Soc Rheumatol, Grp Lupus Study, Hosp San Martin Pl 1st St 1791, RA-1900 Buenos Aires, Argentina
关键词
Damage; hospitalization; systemic lupus erythematosus; DISEASE; VALIDATION; CYCLOPHOSPHAMIDE; CLASSIFICATION; INVOLVEMENT; CRITERIA; DAMAGE; INDEX;
D O I
10.1177/09612033251330077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Admissions are frequent in SLE patients and the main causes are activity of the disease and infections. Objective: To analyze frequency and causes of hospitalizations in SLE patients as well as its main associated factors. MethodsCross sectional study in SLE patients included in RELESSAR registry. Sociodemographic data, autoantibodies, manifestations of the disease and treatments received at the moment of the admission were collected. The sample was divided in two groups according to present or not hospitalization. Number, causes and associated factors to hospitalization were described. Results: A total of 1515 adult SLE patients were analyzed and 53.7% (n: 815) of patients had at least one hospitalization during the evolution of the disease: 203 patients were admitted due to serious infection, 612 patients due to activity of the disease and 162 patients for both reasons. In multivariate analysis, variables independently associated with hospitalization were education level (OR 0.95, 95% CI 0.91-0.99, p = .021), diagnosis delay (OR 0.93, 95% CI 0.88-0.99, p = .029), pleuritis (OR 2.12, 95% CI 1.46-3.10, p < .001), hypocomplementemia (OR 1.96, 95% CI 1.22-3.18, p = .006), use of IvIg (OR 5.87, 95% CI 1.92-26.4, p = .006), use of cyclophosphamide (OR 1.59, 95% CI 1.09-2.34, p = .017) and corticosteroids (<10 mg of prednisone [OR 3.01, 95% CI 1.71-5.47, p < .001], 10-30 mg [12.8, 95% CI 7.53-22.8, p < .001], 30-60 mg/day [OR 22.6, 95% CI 12.1-43.9, p < .001]) and damage (OR 1.29, 95% CI 1.12-1.49, p < .001). Conclusion: More than half of SLE patients had at least one hospitalization and infections and activity of the disease were the most frequent causes. Education level, diagnosis delay, pleuritis, hypocomplementemia, use of IvIg, cyclophosphamide and corticosteroids and damage were associated with admissions.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 50 条
  • [41] Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER)
    Torrente-Segarra, Vicenc
    Salman-Monte, Tarek C.
    Rua-Figueroa, Inigo
    del Campo, Victor
    Javier Lopez-Longo, Francisco
    Galindo-Izquierdo, Maria
    Calvo-Alen, Jaime
    Olive-Marques, Alejandro
    Mourino-Rodriguez, Coral
    Horcada, Loreto
    Bohorquez, Cristina
    Montilla, Carlos
    Salgado, Eva
    Diez-Alvarez, Elvira
    Blanco, Ricardo
    Luis Andreu, Jose
    Fernandez-Berrizbeitia, Olaia
    Exposito, Lorena
    Gantes, Marian
    Hernandez-Cruz, Blanca
    Pecondon-Espanol, Angela
    Lozano-Rivas, Nuria
    Bonilla, Gema
    Lois Iglesias, Ana
    Rubio-Munoz, Paula
    Ovalles, Juan
    Tomero, Eva
    Boteanu, Alina
    Narvaez, Javier
    Freire, Mercedes
    Vela, Paloma
    Quevedo-Vila, Victor
    Juan Mas, Antonio
    Munoz-Fernandez, Santiago
    Raya, Enrique
    Moreno, Mireia
    Velloso-Feijoo, M. L.
    Soler, Gregorio
    Ramon Vazquez-Rodriguez, Tomas
    Pego-Reigosa, Jose M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (04) : 657 - 662
  • [42] THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC) FRAILTY INDEX (SLICC-FI) PREDICTS DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS. DATA FROM A MULTI-ETHNIC, MULTI-CENTER US LUPUS COHORT
    Ugarte-Gil, M. F.
    Dubey, J.
    Mcgwin, G.
    Vila, L.
    Alarcon, G. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 366 - 366
  • [43] Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus
    Torrente-Segarra, V.
    Salman-Monte, T. C.
    Rua-Figueroa, I.
    Perez-Vicente, S.
    Lopez-Longo, F. J.
    Galindo-Izquierdo, M.
    Calvo-Alen, J.
    Olive-Marques, A.
    Ibanez-Ruan, J.
    Horcadam, L.
    Sanchez-Atrio, A.
    Montilla, C.
    Rodriguez-Gomez, M.
    Diez-Alvarez, E.
    Martinez-Taboada, V.
    Andreu, J. L.
    Fernandez-Berrizbeitia, O.
    Hernandez-Beriain, J. A.
    Gantes, M.
    Hernandez-Cruz, B.
    Pecondon-Espanol, A.
    Marras, C.
    Bonilla, G.
    Pego-Reigosa, J. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : S40 - S47
  • [44] Patients' beliefs about the causes of systemic lupus erythematosus
    Taieb, Olivier
    Bricou, Olivier
    Baubet, Thierry
    Gaboulaud, Valerie
    Gal, Beatrice
    Mouthon, Luc
    Dhote, Robin
    Guillevin, Loic
    Moro, Marie Rose
    RHEUMATOLOGY, 2010, 49 (03) : 592 - 599
  • [45] HEMOSTATIC FACTORS ASSOCIATED WITH VASCULAR THROMBOSIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND THE LUPUS ANTICOAGULANT
    MAYUMI, T
    NAGASAWA, K
    INOGUCHI, T
    YAMAUCHI, Y
    ISHII, Y
    TADA, Y
    UMEDA, F
    NIHO, Y
    ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (08) : 543 - 547
  • [46] RISK FACTORS OF REMISSION AND LOW DISEASE ACTIVITY STATE (LDAS) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS. DATA FROM A MULTI-ETHNIC, MULTI-CENTER US COHORT
    Ugarte-Gil, Manuel F.
    Pons-Estel, Guillermo
    Vila, Luis
    McGwin, Gerald, Jr.
    Alarcon, Graciela S.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 69 - 69
  • [47] MORTALITY IN SYSTEMIC LUPUS ERYTHEMATOSUS: CAUSES AND RISK FACTORS IN A GROUP OF TUNISIAN PATIENTS
    Ben Salem, T.
    Tougorti, M.
    Naceur, I.
    Lamloum, M.
    Khanfir, M.
    Ben Ghorbel, I.
    Houman, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1074 - 1074
  • [48] THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS ON WORK PRODUCTIVITY: DATA FROM PATIENTS FROM THE PROVINCE OF CORDOBA, ARGENTINA
    Bertoli, A.
    Lopez Perez, M. J.
    Alba, P.
    Albiero, A.
    Albiero, E.
    Alessio, D.
    Albarelos, A.
    Asbert, P.
    Astesana, P.
    Audisio, M.
    Benzaquen, N.
    Castanos Menescardi, M. S.
    Colazo, M.
    Encinas, L.
    Haye Salinas, M. J.
    Maldini, C.
    Maldoado, A.
    Morales, M. J.
    Onetti, L.
    Saurit, V.
    Savio, V.
    Werner, M.
    Gobbi, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1267 - 1267
  • [49] RELATED FACTORS IN THE DEVELOPMENT OF LUPUS NEPHRITIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Ribas, Andres
    Galceran, Isabel
    Outon, Sara
    Salman, Tarek
    Barrios, Clara
    Ochoa, Adriana S.
    Buxeda, Anna
    Sans, Laia
    Pascual, Julio
    Rodriguez, Eva
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 751 - 751
  • [50] Pregnancy outcomes in patients receiving assisted reproductive therapy with systemic lupus erythematosus: a multi-center retrospective study
    Minxi Lao
    Peiyin Dai
    Guangxi Luo
    Xing Yang
    Miaoguan Peng
    Yuyi Chen
    Yanfeng Zhan
    Zhongping Zhan
    Dongying Chen
    Arthritis Research & Therapy, 25